We are currently preparing for a phase 2 follow-on study SHARON-2.
The answer to your question is yes, semaglutide can cause hair loss
Often, adjusting meal composition or hydration resolves low energy
Tirzepatide is a glucose-dependent insulinotropic polypeptide/GLP- 1 dual receptor agonist (GIP/GLP- 1 RA) and in the Phase 3 SURMOUNT- 1 trial, tirzepatide 5 mg, 10 mg and 15 mg produced mean weight reduction from baseline to week 72 of 15,0%, 18.5% and 20.9%, respectively, versus 2.4% for placebo
This oral peptide is particularly effective for individuals with: Excess visceral (abdominal) fat Metabolic syndrome or insulin resistance Age-related NAD+ decline Fat loss goals while preserving muscle mass GLP-1 users who want to offset muscle loss Its also ideal for people who: Prefer oral therapy over injections Travel frequently and need convenience Want a well-tolerated fat loss support with no stimulant effects How It Compares to Other Peptides Side Effects and Safety To date, no harmful side effects have been reported with oral 5-Amino-1MQ in either animal studies or clinical use